Physician

John R. Mcmanus, M.D.

According to 2025 Medicare claims, John Mcmanus, M.D. (NPI: 1447411277) practices ophthalmology in the Traverse City, MI market, with the plurality of this provider's patient population coming from Grand Traverse, MI. This provider's primary affiliated billing organization is GRAND TRAVERSE OPHTHALMOLOGY CLINIC PC (NPI: 1265426514; TIN: 38-1950606) and primary practice location at 49684-6725. Mcmanus is affiliated with the Northern Michigan Health Network dba NPO-CIN (ACO ID: D0067), participating under the REACH model.

Mcmanus' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,088 traditional Medicare patients, billed 2,961 HCPCS/CPT codes, and received $276,458 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,735 prescription claims across 744 beneficiaries totaling $158,190 in drug costs, led by Restasis (Cyclosporine). 2019 DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $381,879 and ending at $276,458. Concurrently, Part D prescription costs have declined steadily, from $251,298 to $158,190. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,475	3,934	$381,879
2016	1,534	4,220	$411,291
2017	1,606	4,565	$500,462
2018	1,495	4,422	$490,607
2019	1,494	4,549	$547,604
2020	1,299	3,569	$362,052
2021	1,326	3,958	$458,628
2022	1,250	3,356	$345,766
2023	1,039	3,033	$305,906
2024	1,088	2,961	$276,458

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	741	3,686	$251,298
2016	863	3,821	$263,059
2017	888	3,832	$258,337
2018	713	3,641	$285,049
2019	715	3,381	$282,654
2020	706	3,191	$247,374
2021	700	2,809	$201,429
2022	755	2,826	$204,579
2023	731	2,741	$188,526
2024	744	2,735	$158,190

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	24	24	$1,329
2017	12	12	$570
2018	N/R	N/R	N/R
2019	11	11	$631
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	626	646	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	331	398	$56
92083	Exam of visual field with extended testing	308	320	$39
92136	Measurement of corneal curvature and depth of eye	207	319	$26
92133	Imaging of optic nerve	359	362	$22

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	17	1,350	$26,743
Lumigan	Bimatoprost	39	2,805	$22,530
Latanoprost	Latanoprost	1,004	72,590	$19,672
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	495	32,074	$10,856
Brinzolamide	Brinzolamide	46	2,910	$10,212

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for John R. Mcmanus, M.D.?

Tedicare shows public-source Medicare data for John R. Mcmanus, M.D. (NPI 1447411277), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John R. Mcmanus, M.D. have ACO affiliation data?

John R. Mcmanus, M.D. is shown with ACO affiliation data for Northern Michigan Health Network dba NPO-CIN (REACH, ACO ID D0067).

What billing organization is linked to John R. Mcmanus, M.D.?

John R. Mcmanus, M.D. is linked to GRAND TRAVERSE OPHTHALMOLOGY CLINIC PC (billing NPI 1265426514) in the available physician profile data.

Does John R. Mcmanus, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.